TipRanks
Go Ultimate55% OFF

XPRO India Limited (XPROINDIA) AI Stock Analysis

IN:XPROINDIA

XPRO India Limited

(NSE:XPROINDIA)

Select Model
Rating:53Neutral
Price Target:INR 984.00â–¼(-2.74% Downside)
Action:reiterated
Date:08/05/26

Mixed financial performance with balance sheet strengths offset by cash flow weaknesses and income volatility weighs on the score; poor valuation due to high P/E adds downside risk, while neutral-to-positive technicals provide some support.

Positive Factors
Diversified Polymer ApplicationsServing both consumer and industrial end-markets gives XPRO India multiple demand channels rather than reliance on a single application. Its packaging and specialty polymer products can support repeat business where customers require consistent specifications and supply continuity, reinforcing commercial durability.
Negative Factors
Recent Earnings DeteriorationThe latest deterioration in both revenue and net income signals weakening demand, mix, pricing, or operating performance compared with the prior year. A sharp earnings decline reduces internal funding capacity and makes it harder to sustain investment and profitability without operational improvement.

XPRO India Limited (XPROINDIA) vs. iShares MSCI India ETF (INDA)

-30%-20%-10%0%10%20%30%40%IN:XPROINDIA-8.63%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 23.70B
Dividend Yield
0.20%
Average Volume (3M)
9,012
Price to Earnings (P/E)
71.9
Beta (1Y)
1.25
Revenue Growth
-1.23%
EPS Growth
66.26%
Country
India
Employees
658
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

XPRO India Limited Business Overview & Revenue Model

Company Description

Xpro India Limited processes and sells polymers primarily in India. The company offers dielectric films for applications comprising power transmission and distribution, motor run, power film/electronic, magnetic lighting ballast, microwave oven, low...

How the Company Makes Money

XPRO India Limited primarily makes money by manufacturing and selling polymer-based packaging and industrial material products to business customers. Its revenue model is centered on (1) product sales from its manufacturing operations, where earnings...

XPRO India Limited Financial Statement Overview

Summary

Mixed financials with solid revenue growth and strong balance sheet equity expansion, but offset by income volatility, projected declines, and negative free cash flow in later years, indicating sustainability risks.

Income Statement

55Neutral

Balance Sheet

75Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue5.35B5.05B5.35B4.65B5.11B4.72B
Gross Profit1.22B1.05B1.08B1.48B1.61B1.22B
EBITDA687.65M474.16M691.21M763.08M769.51M647.19M
Net Income326.60M192.34M379.97M438.79M453.64M449.32M
Balance Sheet
Total Assets012.18B9.93B6.77B3.40B3.35B
Cash, Cash Equivalents and Short-Term Investments2.98B2.99B2.61B2.05B264.11M193.63M
Total Debt03.25B2.69B390.00M386.82M898.87M
Total Liabilities-7.98B4.20B3.82B1.17B1.07B1.63B
Stockholders Equity7.98B7.60B6.10B5.61B2.34B1.72B
Cash Flow
Free Cash Flow-660.36M-1.14B-2.62B58.15M465.36M420.77M
Operating Cash Flow-20.19M270.46M252.35M439.79M828.55M486.21M
Investing Cash Flow-1.41B-1.75B-1.31B-3.20B-582.75M-104.59M
Financing Cash Flow806.86M1.58B2.08B2.78B-431.40M-211.58M

XPRO India Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price1011.75

Price Trends

50DMA1143.92Negative
100DMA1226.80Negative
200DMA1115.91Negative

Market Momentum

MACD-45.87Negative
RSI39.62Neutral
STOCH39.06Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:XPROINDIA, the sentiment is Negative. The current price of 1011.75 is below the 20-day moving average (MA) of 1038.18, below the 50-day MA of 1143.92, and below the 200-day MA of 1115.91, indicating a bearish trend. The MACD of -45.87 indicates Negative momentum. The RSI at 39.62 is Neutral, neither overbought nor oversold. The STOCH value of 39.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:XPROINDIA.

XPRO India Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:XPROINDIA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:FCLIN:FCL69NeutralINR 56.58B40.33―0.27%91.44%19.67%
IN:NOCILIN:NOCIL67NeutralINR 22.92B34.63―1.09%0.96%-28.98%
IN:ROSSARIIN:ROSSARI65NeutralINR 22.12B14.48―0.13%19.76%11.74%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:TATVAIN:TATVA55NeutralINR 38.49B61.11―0.12%49.69%254.75%
IN:XPROINDIAIN:XPROINDIA53NeutralINR 23.75B71.87―0.20%-1.23%66.26%
IN:NEOGENIN:NEOGEN46NeutralINR 65.47B163.88―0.05%18.00%3.85%

* General Sector Average

Performance Comparison

0%50%IN:XPROINDIAIN:FCLIN:NEOGENIN:NOCILIN:ROSSARIIN:TATVADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:XPROINDIA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:XPROINDIAXPRO India Limited1011.75-82.94-7.58%
IN:FCLFineotex Chemical Limited48.5916.5551.67%
IN:NEOGENNeogen Chemicals Ltd.2179.35717.5649.09%
IN:NOCILNOCIL Limited137.20-42.32-23.58%
IN:ROSSARIRossari Biotech Ltd399.25-242.58-37.79%
IN:TATVATatva Chintan Pharma Chem Limited1645.45235.4016.69%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 05, 2026